Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Cd7em1/Cya
Common Name:
Cd7-KO
Product ID:
S-KO-01429
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Cd7-KO
Strain ID
KOCMP-12516-Cd7-B6J-VA
Gene Name
Cd7
Product ID
S-KO-01429
Gene Alias
--
Background
C57BL/6JCya
NCBI ID
12516
Modification
Conventional knockout
Chromosome
11
Phenotype
MGI:88344
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Cd7em1/Cya mice (Catalog S-KO-01429) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000026159
NCBI RefSeq
NM_009854
Target Region
Exon 2~4
Size of Effective Region
~1.6 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Cd7, an antigen belonging to the immunoglobulin superfamily, is expressed on the surface of all thymocytes, most mature T cells, and natural killer cells. It has proposed functions in T-cell activation and intercellular adhesiveness [4].

In the context of T-cell malignancies, CD7 is a transmembrane protein highly expressed in acute T-cell leukemia (T-ALL) and some peripheral T-cell lymphomas. Targeting CD7 with chimeric antigen receptor (CAR) T cells has been explored, but the major challenge is CAR T-cell fratricide due to CD7 expression on both normal and malignant cells. Strategies like genetic manipulations to ablate the CD7 gene [1], using protein expression blockers to downregulate CD7 [3], or pharmacologic inhibition of key CAR/CD3ζ signaling kinases [2] have been employed to overcome this. For instance, CD7-edited T cells can expand without compromising cytotoxic function against malignant T-cell lines and primary tumors in mouse xenograft models of T-ALL [1].

In conclusion, Cd7 is significant in T-cell biology. Its high expression in T-cell malignancies makes it a potential target for immunotherapy. However, the issue of fratricide in CD7-targeted CAR T-cell therapy has been a major hurdle. Studies using gene-editing techniques, similar to gene knockout approaches, have been crucial in understanding how to overcome this and develop effective treatments for T-cell malignancies [1,2,3].

References:

1. Gomes-Silva, Diogo, Srinivasan, Madhuwanti, Sharma, Sandhya, Brenner, Malcolm K, Mamonkin, Maksim. 2017. CD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell malignancies. In Blood, 130, 285-296. doi:10.1182/blood-2017-01-761320. https://pubmed.ncbi.nlm.nih.gov/28539325/

2. Watanabe, Norihiro, Mo, Feiyan, Zheng, Rong, Brenner, Malcolm K, Mamonkin, Maksim. 2022. Feasibility and preclinical efficacy of CD7-unedited CD7 CAR T cells for T cell malignancies. In Molecular therapy : the journal of the American Society of Gene Therapy, 31, 24-34. doi:10.1016/j.ymthe.2022.09.003. https://pubmed.ncbi.nlm.nih.gov/36086817/

3. Png, Yi Tian, Vinanica, Natasha, Kamiya, Takahiro, Coustan-Smith, Elaine, Campana, Dario. 2017. Blockade of CD7 expression in T cells for effective chimeric antigen receptor targeting of T-cell malignancies. In Blood advances, 1, 2348-2360. doi:10.1182/bloodadvances.2017009928. https://pubmed.ncbi.nlm.nih.gov/29296885/

4. Haftcheshmeh, Saeed Mohammadian, Tajbakhsh, Amir, Kazemi, Mohaddese, Fazeli, Mostafa, Sahebkar, Amirhossein. 2018. The clinical importance of CD4+ CD7- in human diseases. In Journal of cellular physiology, 234, 1179-1189. doi:10.1002/jcp.27099. https://pubmed.ncbi.nlm.nih.gov/30067877/

Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest